Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.57 |
| ▸ | DPP4 | P27487 | 1/20 | 0.57 |
| ▸ | MEN1 | O00255 | 1/20 | 0.57 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.57 |
| ▸ | MAP3K7 | O43318 | 1/20 | 0.57 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.57 |
| ▸ | GAPDH | P04406 | 1/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.57 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.57 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.57 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.57 |
| ▸ | STAT6 | P42226 | 1/20 | 0.57 |
| ▸ | PI4KA | P42356 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.57 |
| ▸ | PI4K2B | Q8TCG2 | 1/20 | 0.57 |
| ▸ | DOT1L | Q8TEK3 | 1/20 | 0.57 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.57 |
| ▸ | PI4K2A | Q9BTU6 | 1/20 | 0.57 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25390968 | 1.00 | ADORA3 (0.57) | ADORA3DPP4MEN1SLC28A1MAP3K7 | |
| SCHEMBL13844404 | 0.91 | PRMT5 (0.61) | ADORA3DPP4MEN1SLC28A1MAP3K7 | |
| SCHEMBL31725323 | 0.85 | AHCY (0.49) | ADORA3ADORA2AADORA2BADORA1SLC29A1 | |
| SCHEMBL31725350 | 0.84 | NT5E (0.60) | ADORA3ADORA2AADORA2BADORA1AHCY | |
| SCHEMBL15203798 | 0.84 | ADORA3 (0.54) | ADORA3DPP4MEN1SLC28A1MAP3K7 | |
| SCHEMBL16998142 | 0.84 | ADORA3 (0.54) | ADORA3DPP4MEN1SLC28A1MAP3K7 | |
| SCHEMBL31725329 | 0.83 | PRMT5 (0.48) | ADORA3DPP4MEN1SLC28A1MAP3K7 | |
| SCHEMBL31725331 | 0.82 | AHCY (0.53) | ADORA3ADORA2AADORA2BPRMT5WDR77 | |
| SCHEMBL561654 | 0.81 | PRMT5 (0.64) | ADORA3DPP4MEN1SLC28A1MAP3K7 | |
| SCHEMBL561516 | 0.81 | PRMT5 (0.64) | ADORA3DPP4MEN1SLC28A1MAP3K7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025235664-A1 | PURINE NUCLEOTIDE AND NUCLEOSIDE THERAPEUTIC COMPOSITIONS AND USES RELATED THERETO | EMORY UNIVERSITY (US) | 2025-11-13 | — | — | WO | disclosed |
| US-20230277575-A1 | Nucleoside Analogues to Inhibit the Main Protease of a Coronavirus | Institut de Recherche en Semiochimie et Ethologie Appliquee (FR) | 2023-09-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230277575-A1 | Nucleoside Analogues to Inhibit the Main Protease of a Coronavirus | ACE, ACE2, METAP1 | ADORA3 611/4885DPP4 44/4885MEN1 3079/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.